Palladini G - Search Results

1

Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA.

Palladini G, Kastritis E, Maurer MS, Zonder J, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Bumma N, Kaufman JL, Medvedova E, Kovacsovics T, Rosenzweig M, Sanchorawala V, Qin X, Vasey SY, Weiss BM, Vermeulen J, Merlini G, Comenzo RL. Palladini G, et al. Blood. 2020 Jul 2;136(1):71-80. doi: 10.1182/blood.2019004460. Blood. 2020. PMID: 32244252 Free PMC article. Clinical Trial.

2

Abnormalities in thrombin-antithrombin pathway in AL amyloidosis.

Gamba G, Montani N, Anesi E, Palladini G, Lorenzutti F, Perfetti V, Merlini G. Gamba G, et al. Among authors: palladini g. Amyloid. 1999 Dec;6(4):273-7. doi: 10.3109/13506129909007339. Amyloid. 1999. PMID: 10611948

3

Clotting alterations in primary systemic amyloidosis.

Gamba G, Montani N, Anesi E, Palladini G, Capezzera M, Soldavini E, Merlini G. Gamba G, et al. Among authors: palladini g. Haematologica. 2000 Mar;85(3):289-92. Haematologica. 2000. PMID: 10702818

4

A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis.

Palladini G, Anesi E, Perfetti V, Obici L, Invernizzi R, Balduini C, Ascari E, Merlini G. Palladini G, et al. Br J Haematol. 2001 Jun;113(4):1044-6. doi: 10.1046/j.1365-2141.2001.02859.x. Br J Haematol. 2001. PMID: 11442500 Free article.

5

Holter monitoring in AL amyloidosis: prognostic implications.

Palladini G, Malamani G, Cò F, Pistorio A, Recusani F, Anesi E, Garini P, Merlini G. Palladini G, et al. Pacing Clin Electrophysiol. 2001 Aug;24(8 Pt 1):1228-33. doi: 10.1046/j.1460-9592.2001.01228.x. Pacing Clin Electrophysiol. 2001. PMID: 11523608

6

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

Gertz MA, Lacy MQ, Dispenzieri A, Cheson BD, Barlogie B, Kyle RA, Palladini G, Geyer SM, Merlini G. Gertz MA, et al. Among authors: palladini g. Amyloid. 2002 Mar;9(1):24-30. doi: 10.3109/13506120209072441. Amyloid. 2002. PMID: 12000194 Clinical Trial.

7

Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G. Perfetti V, et al. Among authors: palladini g. Blood. 2002 Aug 1;100(3):948-53. doi: 10.1182/blood-2002-01-0114. Blood. 2002. PMID: 12130507 Free article.

8

Hereditary amyloidosis.

Palladini G, Obici L, Merlini G. Palladini G, et al. N Engl J Med. 2002 Oct 10;347(15):1206-7; author reply 1206-7. doi: 10.1056/NEJM200210103471517. N Engl J Med. 2002. PMID: 12374886 No abstract available.

9

Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?

Bernardi L, Passino C, Porta C, Anesi E, Palladini G, Merlini G. Bernardi L, et al. Among authors: palladini g. Heart. 2002 Dec;88(6):615-21. doi: 10.1136/heart.88.6.615. Heart. 2002. PMID: 12433892 Free PMC article. Clinical Trial.

10

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril GM, Moratti R, Merlini G. Palladini G, et al. Circulation. 2003 May 20;107(19):2440-5. doi: 10.1161/01.CIR.0000068314.02595.B2. Epub 2003 Apr 28. Circulation. 2003. PMID: 12719281 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page